Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

Osteoporosis Drug Shows Promise, No Side Effects

By Harry Kimball,  Newser Staff

Posted Aug 11, 2009 4:22 PM CDT

(Newser) – An experimental drug could drastically decrease the risk of bone breakage in osteoporosis sufferers, Time reports. Two trials of the drug denosumab in groups at high risk for the disease—men receiving testosterone-depleting treatment for prostate cancer and post-menopausal women—reduced the risk of fracture by more than 50%, with no side effects. Other drugs carry the risk of cancer. Denosumab is currently under review by the FDA.

The male study group had a 62% lower risk of spinal fracture over 3 years than the control; for the female group, that number was 68%. “This really addresses an unmet medical need for fracture prevention in men receiving androgen-deprivation therapy for prostate cancer,” one of the authors says. The new therapy is only as effective as a once-a-year injection already on the market, but its lack of side effects could make it a safer alternative.

A broken bone.
A broken bone.   (AP Photo)
« Prev« Prev | Next »Next » Slideshow

How much impact this would have on patient care remains to be seen.
- Dr. Sundeep Khosla, Mayo Clinic

« Prev« Prev | Next »Next » Slideshow
To report an error on this story, notify our editors.
A snapshot of the day's best news stories.
 
COMMENTS
Showing 1 of 1 comment
Scrambles
Aug 11, 2009 9:35 AM CDT
What a great breakthrough, however its hard to believe that there are NO side effects to a drug...

More Newser Stories

Pregnant Women in 50s Do Just Fine

Women Getting Shorter, Heavier

Heart Pills Curb Risk of Prostate Cancer: Study

Discovery Spurs Hope for Prostate Cancer Test

Gene Discovery Raises Breast Cancer Hopes


NEWS FROM OUR PARTNERS
Other Sites We Like:   24/7 Wall St.   |   Betty Confidential   |   BuzzFeed   |   Cracked   |   Fark   |   Timelines   |   The Frisky   |   Geek Sugar   |   NewsOne